Monoclonal antibodies can block a key immune-related protein that drives the spread of brain cell damage in Parkinson's ...

Rebecca King Crews talks about how husband Terry first told her about a new FDA approval for focused ultrasound for treating ...

Meta CEO Mark Zuckerberg backed-Cellular Intelligence has acquired Danish drugmaker Novo Nordisk's cell therapy candidate for ...

The U.S. Food and Drug Administration is reviewing a new Parkinson’s disease drug called tavapadon that could give people with the disease more control over their movements. If approved, it would be ...

Parkinson’s disease currently affects nearly one million Americans with no specific known cause and no cure. Treatments have come a long way over the past few decades focusing on managing symptoms and ...

The deal gives Cellular Intelligence control of a clinical-stage therapy designed to restore the dopamine-producing nerve ...

The approval of Sumitomo Pharma's Amchepry makes it the world's first commercialized medical product derived from iPS cells.

The age-old advice to "trust your gut" could soon take on new meaning for people diagnosed with Parkinson's disease, thanks to a creative feat of bioengineering by researchers in the University of ...

A Japanese health ministry panel on Wednesday approved public health insurance coverage for a regenerative medicine product ...